chr10-94989183-C-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000771.4(CYP2C9):​c.*155C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000731 in 1,367,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.3e-7 ( 0 hom. )

Consequence

CYP2C9
NM_000771.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.71

Publications

0 publications found
Variant links:
Genes affected
CYP2C9 (HGNC:2623): (cytochrome P450 family 2 subfamily C member 9) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000771.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2C9
NM_000771.4
MANE Select
c.*155C>A
3_prime_UTR
Exon 9 of 9NP_000762.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2C9
ENST00000260682.8
TSL:1 MANE Select
c.*155C>A
3_prime_UTR
Exon 9 of 9ENSP00000260682.6P11712-1
CYP2C9
ENST00000880948.1
c.*155C>A
3_prime_UTR
Exon 9 of 9ENSP00000551007.1
CYP2C9
ENST00000880956.1
c.*155C>A
3_prime_UTR
Exon 9 of 9ENSP00000551015.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.31e-7
AC:
1
AN:
1367932
Hom.:
0
Cov.:
31
AF XY:
0.00000149
AC XY:
1
AN XY:
672984
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31100
American (AMR)
AF:
0.00
AC:
0
AN:
33380
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23000
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36822
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74570
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3956
European-Non Finnish (NFE)
AF:
9.35e-7
AC:
1
AN:
1069728
Other (OTH)
AF:
0.00
AC:
0
AN:
56846
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.25
DANN
Benign
0.70
PhyloP100
-1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9332243; hg19: chr10-96748940; API